Accelrys' Q1 Revenues Rise 7 Percent but Fall Short of Estimates

May 01, 2013

|

NEW YORK (GenomeWeb News) – Accelrys said after the close of the market on Tuesday that its first-quarter revenues were up 7 percent year over year.

Total revenues for the three months ended March 31 were $42.1 million, compared to $39.4 million for the first quarter a year ago, short of the average Wall Street estimate of $45.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Featured White Papers

Automated Rare Disease Diagnostics

Main menu